SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (2371)10/22/2008 5:40:09 PM
From: Jibacoa  Respond to of 3722
 
AVGN was able to bounce up a little after yesterday's tanking.<g>

Today's volume although way ahead of its ADV, was about 1/6 of yesterday 20.382M.<g>

Yesterday was when it announced that its AV650, or tolperisone HCI, for MS, failed to hit its primary goal of reducing patients’ Ashworth scores, which measures increased resistance to passive limb movement, compared to placebo, and its secondary target of reducing muscle spasms.

bigcharts.marketwatch.com

Bernard